Novel microtubule-targeting agents – the epothilones
Kit L Cheng, Thomas Bradley, Daniel R Budman1Monter Cancer Center, North Shore – LIJ Health Systems, Lake Success, New York, USAAbstract: Epothilones are a new class of antimicrotubule agents currently in clinical trials. Their chemical structures are distinct from taxanes and are more...
Guardado en:
Autores principales: | Daniel R Budman, Thomas Bradley, Kit L Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72e05137839c4d13b14316ea5a51b046 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epothilone D alters normal growth, viability and microtubule dependent intracellular functions of cortical neurons in vitro
por: J. A. Clark, et al.
Publicado: (2020) -
Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer
por: Liping Chu, et al.
Publicado: (2010) -
Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
por: Wang Z, et al.
Publicado: (2012) -
Metastatic gastric cancer – focus on targeted therapies
por: Meza-Junco J, et al.
Publicado: (2012) -
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
por: Linda Wordeman, et al.
Publicado: (2021)